AU2001280809A1 - Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel - Google Patents
Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channelInfo
- Publication number
- AU2001280809A1 AU2001280809A1 AU2001280809A AU8080901A AU2001280809A1 AU 2001280809 A1 AU2001280809 A1 AU 2001280809A1 AU 2001280809 A AU2001280809 A AU 2001280809A AU 8080901 A AU8080901 A AU 8080901A AU 2001280809 A1 AU2001280809 A1 AU 2001280809A1
- Authority
- AU
- Australia
- Prior art keywords
- activators
- analogs
- chloride channel
- calcium dependent
- dependent chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108010073491 Ace toxin Proteins 0.000 title 1
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title 1
- 108010062745 Chloride Channels Proteins 0.000 title 1
- 102000011045 Chloride Channels Human genes 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 229910052791 calcium Inorganic materials 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 230000001419 dependent effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22211000P | 2000-07-28 | 2000-07-28 | |
| US60/222,110 | 2000-07-28 | ||
| PCT/US2001/023530 WO2002009642A2 (en) | 2000-07-28 | 2001-07-27 | Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001280809A1 true AU2001280809A1 (en) | 2002-02-13 |
Family
ID=22830871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001280809A Abandoned AU2001280809A1 (en) | 2000-07-28 | 2001-07-27 | Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7582424B2 (en) |
| EP (1) | EP1365786A4 (en) |
| AU (1) | AU2001280809A1 (en) |
| CA (1) | CA2416156A1 (en) |
| WO (1) | WO2002009642A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8714157B2 (en) | 2003-09-03 | 2014-05-06 | Fisher & Paykel Healthcare Limited | Mask |
| US7169609B2 (en) * | 2004-03-31 | 2007-01-30 | Vertex Pharmaceutcals, Inc. | Multiwell plate assembly for use in high throughput assays |
| AU2010286248A1 (en) * | 2009-08-28 | 2012-04-12 | The Hospital For Sick Children | Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins |
| WO2023141154A1 (en) | 2022-01-20 | 2023-07-27 | Illumina Cambridge Limited | Methods of detecting methylcytosine and hydroxymethylcytosine by sequencing |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4328209A (en) | 1979-04-11 | 1982-05-04 | Board Of Regents, The University Of Texas System | Cholera vaccine |
| CH645270A5 (en) | 1979-10-11 | 1984-09-28 | Schweiz Serum & Impfinst | Vaccine against coli bacillosis of piglets and process for its preparation |
| US5470729A (en) * | 1983-03-04 | 1995-11-28 | University Of Maryland At Baltimore | Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof |
| US5674898A (en) * | 1990-03-05 | 1997-10-07 | Genzyme Corporation | Methods and therapeutic compositions for treating cystic fibrosis |
| ES2216005T3 (en) | 1993-11-09 | 2004-10-16 | Targeted Genetics Corporation | PRODUCTION OF ELEVATED TITLES OF RECOMBINANT AAV VECTORS. |
| US5602110A (en) | 1994-08-31 | 1997-02-11 | Case Western Reserve University | Method and composition for treating cystic fibrosis |
| US6077826A (en) * | 1996-01-25 | 2000-06-20 | Kansas State University Research Foundation | Synthetic macromolecular channel assembly for transport of chloride ions through epithelium useful in treating cystic fibrosis |
| CA2251727A1 (en) * | 1996-04-22 | 1997-10-30 | Wayne Lencer | Regulation of cellular volume via chloride conductive polypeptide channels |
-
2001
- 2001-07-27 CA CA002416156A patent/CA2416156A1/en not_active Abandoned
- 2001-07-27 US US10/333,610 patent/US7582424B2/en not_active Expired - Fee Related
- 2001-07-27 AU AU2001280809A patent/AU2001280809A1/en not_active Abandoned
- 2001-07-27 WO PCT/US2001/023530 patent/WO2002009642A2/en not_active Ceased
- 2001-07-27 EP EP01959227A patent/EP1365786A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1365786A2 (en) | 2003-12-03 |
| US7582424B2 (en) | 2009-09-01 |
| WO2002009642A3 (en) | 2003-08-28 |
| WO2002009642A2 (en) | 2002-02-07 |
| EP1365786A4 (en) | 2005-06-08 |
| CA2416156A1 (en) | 2002-02-07 |
| US20040110672A1 (en) | 2004-06-10 |
| WO2002009642A9 (en) | 2003-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0127093D0 (en) | Determination of effective composition of a mixture of hydracarbon gases | |
| AU2001266068A1 (en) | Treatment of mineral substrates | |
| IL157004A0 (en) | Novel mixtures of microbial enzymes | |
| AU2002348804A1 (en) | Visualization of entertainment content | |
| AU2001233081A1 (en) | Composition for treatment of stress | |
| AU2001236985A1 (en) | Treatment of molecular sieves with silicon containing compounds | |
| AU2003243714A1 (en) | Etoposide analogs and methods of use thereof | |
| AU2001293372A1 (en) | Substituted 1,4-thiazepine and analogs and their use as activators of caspases | |
| GB0100110D0 (en) | Modulation of calcium channel activity | |
| AU2001270240A1 (en) | Human calcium channels (48000; 52920) and uses thereof | |
| AU2002231206A1 (en) | Treatment of depression | |
| AU2002220378A1 (en) | Regulation of bacterial virulence | |
| AU2001280809A1 (en) | Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel | |
| AU2003254978A1 (en) | Device for treating air of air-fuel mixture | |
| AU2002328920A1 (en) | Emulsifier mixture | |
| AU2002223544A1 (en) | Distribution of content | |
| AU2002342901A1 (en) | Emulsifier mixture | |
| AU2951399A (en) | Treatment of phospho gypsum | |
| AU2002358719A1 (en) | Agaricoglycerides and analogs | |
| AU2001245092A1 (en) | Sterilization of elongate lumens | |
| GB9923951D0 (en) | Treatment of gas mixture | |
| AU2002238460A1 (en) | Regulation of human calcium channel | |
| TW437909U (en) | Soft start device of lighting | |
| AU2001218028A1 (en) | Sterilization of elongate lumens | |
| AU7057701A (en) | New use as antihelmintics of albofungin and analogs |